Literature DB >> 25941261

Can reporting of adverse drug reactions create safer systems while improving health data?

Corinne Hohl1, Joel R Lexchin2, Ellen Balka2.   

Abstract

Mesh：

Year:  2015        PMID： 25941261      PMCID： PMC4527894          DOI： 10.1503/cmaj.150057

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Emergency hospitalizations for adverse drug events in older Americans.

Authors:  Daniel S Budnitz; Maribeth C Lovegrove; Nadine Shehab; Chesley L Richards
Journal:  N Engl J Med       Date:  2011-11-24       Impact factor: 91.245

2.  Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study.

Authors:  Peter J Zed; Riyad B Abu-Laban; Robert M Balen; Peter S Loewen; Corinne M Hohl; Jeffrey R Brubacher; Kerry Wilbur; Matthew O Wiens; Leslie J Samoy; Katie Lacaria; Roy A Purssell
Journal:  CMAJ       Date:  2008-06-03       Impact factor: 8.262

Review 3.  Regulating prescription drugs for patient safety: does Bill C-17 go far enough?

Authors:  Matthew Herder; Elaine Gibson; Janice Graham; Joel Lexchin; Barbara Mintzes
Journal:  CMAJ       Date:  2014-03-10       Impact factor: 8.262

4.  Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis.

Authors:  Nicole Mittmann; Sandra R Knowles; Manuel Gomez; Joel S Fish; Robert Cartotto; Neil H Shear
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  Evaluating adverse drug event reporting in administrative data from emergency departments: a validation study.

Authors:  Corinne M Hohl; Lisa Kuramoto; Eugenia Yu; Basia Rogula; Jürgen Stausberg; Boris Sobolev
Journal:  BMC Health Serv Res       Date:  2013-11-12       Impact factor: 2.655
  5 in total
  4 in total

1.  Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework.

Authors:  Raymond Li; Kate Curtis; Connie Van; Syed Tabish Razi Zaidi; Chin Yen Yeo; Christina Arun Kali; Mithila Zaheen; Grace Therese Moujalli; Ronald Castelino
Journal:  Eur J Clin Pharmacol       Date:  2022-04-27       Impact factor: 3.064

2.  A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.

Authors:  Steven G Morgan; Marc-André Gagnon; Barbara Mintzes; Joel Lexchin
Journal:  Healthc Policy       Date:  2016-08

3.  Using ActionADE to create information continuity to reduce re-exposures to harmful medications: study protocol for a randomized controlled trial.

Authors:  Jeffrey P Hau; Penelope M A Brasher; Amber Cragg; Serena Small; Maeve Wickham; Corinne M Hohl
Journal:  Trials       Date:  2021-02-05       Impact factor: 2.279

4.  Why Clinicians Don't Report Adverse Drug Events: Qualitative Study.

Authors:  Corinne M Hohl; Serena S Small; David Peddie; Katherin Badke; Ellen Balka; Chantelle Bailey
Journal:  JMIR Public Health Surveill       Date:  2018-02-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.